Statements of Cash Flows - USD ($)	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,488,659)	$ (4,072,455)
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued as compensation	100,792	108,648
Loss on issuance of preferred shares for accounts payable- related party	142,669	0
Common shares issued as compensation and for services	76,500	125,210
Warrants granted to Scientific Advisory Board	1,441	2,972
Stock-based compensation expense	0	11,920
Depreciation	345,674	343,135
Amortization of loan origination fees	1,638	0
Amortization	4,135	4,136
Change in fair value of derivative liability	(274,449)	(298,092)
Changes in operating assets and liabilities:
Prepaid expenses	12,382	71,309
Other assets	7,820	2,850
Accounts payable	362,464	442
Accounts payable - related party	163,587	693,362
Accrued expenses	(16,239)	(114,000)
NET CASH USED IN OPERATING ACTIVITIES	(2,560,245)	(3,120,563)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(4,139)	(57,536)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from note payable to related party	1,100,000	0
Deferred issuance costs	(383,175)	0
NET CASH PROVIDED BY FINANCING ACTIVITIES	716,825	0
NET CHANGE IN CASH AND CASH EQUIVALENTS	(1,847,559)	(3,178,099)
Cash and cash equivalents at beginning of period	2,555,207	7,081,771
Cash and cash equivalents at end of period	707,648	3,903,672
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid	0	0
Non-cash Financing and Investing Activities:
Series A preferred stock issued for accounts payable-related party	250,000	0
Series A preferred stock issued for loan origination fee	$ 39,301	$ 0